Ledger.Open graph →

SEC Form D · filed April 3, 2024

RedShift BioAnalytics, Inc

Offering

$7.0M

Sold

$5.0M

Exemption

Rule 506(b)

Industry

Other Technology

Location

Boxborough, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Wouter Meuleman · Boxborough, MADirector Thomas O'Lenic · Boxborough, MAExec · Director Bryson Hollimon · Boxborough, MADirector William Cadogan · Boxborough, MADirector Frank Smith · Boxborough, MADirector Thomas O'Lenic · Boxborough, MAExec · Director William Cadogan · Boxborough, MADirector Frank Smith · Boxborough, MADirector Bryson Hollimon · Boxborough, MADirector Wouter Meuleman · Boxborough, MADirector Mark Cafazzo · Boxborough, MADirector Amol Chaubal · Marlborough, MADirector Igor S. Merk · Kaneohe, HIDirector Alexander Silva · Kailua, HIDirector Sean Warnet · Waipahu, HIDirector Koliah S. Ramirez · Wahiawa, HIExec · Director Alfred S. Paclib · Aiea, HIDirector Mark Cafazzo · Boxborough, MADirector Amol Chaubal · Burlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗